Evidence map›Paper›PMID 34408813›Full record

ArticleAnimal cells and systems2021

Time-sequential change in immune-related gene expression after irradiation in glioblastoma: next-generation sequencing analysis.

Yi-Jun Kim, Kwangsoo Kim, Soo Yeon Seo, Juyeon Yu, Il Han Kim, Hak Jae Kim, Chul-Kee Park, Kye Hwa Lee, Junjeong Choi, Myung Seon Song and 1 more

Open access · goldAbstract read
In one paragraph

Article in Animal cells and systems, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Yi-Jun KimDepartment of Radiation Oncology, Seoul National University College of Medicine, Seoul, Republic of Korea.
Kwangsoo KimTransdisciplinary Department of Medicine & Advanced Technology, Seoul National University Hospital, Seoul, Republic of Korea.
Soo Yeon SeoCancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
Juyeon YuCancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
Il Han KimDepartment of Radiation Oncology, Seoul National University College of Medicine, Seoul, Republic of Korea.
Hak Jae KimDepartment of Radiation Oncology, Seoul National University College of Medicine, Seoul, Republic of Korea.
Chul-Kee ParkDepartment of Neurosurgery, Seoul National University College of Medicine, Seoul, Republic of Korea.
Kye Hwa LeeDepartment of Information Medicine, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Republic of Korea.
Junjeong ChoiYonsei Institute of Pharmaceutical Sciences, College of Pharmacy, Yonsei University, Incheon, Republic of Korea.
Myung Seon SongDepartment of Psychiatry, Keyo Hospital, Uiwang, Republic of Korea.
Jin Ho KimDepartment of Radiation Oncology, Seoul National University College of Medicine, Seoul, Republic of Korea.
Seoul National University · KRSeoul National University Hospital · KRUlsan College · KRYonsei University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The time-sequential change in immune-related gene expression of the glioblastoma cell line after irradiation was evaluated to speculate the effect of combined immunotherapy with radiotherapy. The U373 MG glioblastoma cell line was irradiated with 6 Gy single dose. Next-generation sequencing (NGS) transcriptome data was generated before irradiation (control), and at 6, 24, and 48 h post-irradiation. Immune-related pathways were analyzed at each time period. The same analyses were also performed for A549 lung cancer and U87 MG glioblastoma cell lines. Western blotting confirmed the programmed death-ligand 1 (PD-L1) expression levels over time. In the U373 MG cell line, neutrophil-mediated immunity, type I interferon signaling, antigen cross-presentation to T cell, and interferon-

Indexed as

GlioblastomaImmune-related signalsNext-generation sequencingRadiotherapyTranscriptome

Identifiers

PMID34408813
PMCPMC8366673
OpenAlexW3113408773

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.